March 01, 2018
Former Hunton & Williams LLP patent lawyer Robert Schulman asked the Second Circuit to give him an acquittal after being convicted and sentenced to probation for passing a nebulous trading tip to his friend and financial adviser, saying the government didn't show an essential element: intent that it would be traded on.
February 12, 2018
A financial adviser who copped to trading King Pharmaceuticals stock after a tipsy lawyer shared inside information with him at dinner was sentenced to six months in prison on Monday by a Brooklyn federal judge, harsher than the sentence faced by the attorney who tipped him.
September 26, 2017
A former Hunton & Williams LLP attorney was sentenced by a Brooklyn federal judge on Tuesday to three years probation for his securities fraud and conspiracy convictions after he drunkenly tipped off his friend and investment adviser about Pfizer Inc.'s plans to acquire his drugmaker client.
September 22, 2017
A former Hunton & Williams LLP patent partner who hinted to a friend about an upcoming Pfizer deal asked a New York federal judge to sentence him to probation for his securities fraud and conspiracy conviction, citing his kindhearted acts and restating his claim that he does not recall tipping off his friend, according to court documents made public Friday.
September 19, 2017
Federal prosecutors are calling a former Hunton & Williams LLP patent partner's hints about an upcoming Pfizer deal an "inexcusable breach of trust" by someone professionally tasked with protecting corporate secrets, and asked for a sentence of at least 51 months following the lawyer's March conviction in New York federal court.
September 12, 2017
A New York federal judge on Tuesday denied bids for acquittal and a new trial from a former Hunton & Williams LLP patent lawyer who was convicted of insider trading for tipping off his friend and investment adviser about Pfizer Inc.'s plans to acquire a client.
August 17, 2017
Federal prosecutors urged a New York federal court on Wednesday to deny former Hunton & Williams LLP patent lawyer Robert Schulman's bids for acquittal and a new trial, saying his new arguments about the government's supposed failure to prove a single insider trading conspiracy between him, his investment adviser and a friend of the adviser are "meritless."
July 25, 2017
A former investment adviser admitted in Brooklyn federal court on Tuesday that he schemed to trade on inside information that a convicted ex-Hunton & Williams LLP attorney gleaned from a pharmaceutical industry client.
June 23, 2017
Robert Schulman, the former Hunton & Williams LLP patent lawyer convicted of insider trading on a Pfizer deal, has tapped a Proskauer Rose LLP appellate partner for his post-verdict defense, a Thursday filing said.
April 25, 2017
The insider trading conviction of former Hunton & Williams LLP patent lawyer Rob Schulman was based on insufficient evidence that he meant to profit from tipping an investment adviser about Pfizer Inc.'s plans to acquire his drugmaker client, Schulman argued in a pair of filings Monday in New York federal court.